Article

Warburg Pincus acquires B&L

Warburg Pincus has completed its acquisition of Bausch & Lomb (B&L) for a total purchase price of approximately $4.5 billion, including nearly $830 million of debt.

Rochester, NY-Warburg Pincus has completed its acquisition of Bausch & Lomb (B&L) for a total purchase price of approximately $4.5 billion, including nearly $830 million of debt.

"With a strong and supportive partner in Warburg Pincus, we are well positioned to create new opportunities for Bausch & Lomb and advance our leadership in the eye health industry," said Ronald L. Zarrella, chairman and chief executive officer of B&L.

Elizabeth H. Weatherman, a Warburg Pincus managing director, said, "We're delighted to be partners with B&L. We look forward to helping the company build upon its rich heritage and premier brand in ophthalmology."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
1 expert in this video
© 2025 MJH Life Sciences

All rights reserved.